The largest database of trusted experimental protocols

Pegfp c1 plasmid

Manufactured by Takara Bio
Sourced in United States

The PEGFP-C1 plasmid is a circular DNA molecule that can be used for the expression of proteins fused to the green fluorescent protein (GFP) in mammalian cells. The plasmid contains the GFP gene under the control of a strong constitutive promoter, which enables the expression and visualization of the target protein.

Automatically generated - may contain errors

55 protocols using pegfp c1 plasmid

1

Assessing Transfection Efficiency with pEGFP-C1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pEGFP-C1 plasmid (Takara Bio Europe, Saint-Germain-en-Laye, France) encoding GFP (Green Fluorescent Protein) was adopted to assess transfection efficacy [25 (link)]. Plasmid DNA was amplified using standard protocols to yield a concentration of 5 μg/μL.
+ Open protocol
+ Expand
2

RNA Interference Silencing of Insect Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TcTRPA1 and TcOrco gene templates containing the T7 promoter sequence at the 5′ end were amplified with primers (Supplementary Table S1) using KOD Plus Neo (TOYOBO) under the following conditions: 94 °C for 2 min, 40 cycles at 98 °C for 10 s, 58 °C for 30 s, and 68 °C for 1 min. The amplified templates were used for the synthesis of dsRNA using the RiboMAX Large-Scale RNA Production System T7 (Promega). The dsRNA products were quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Inc., Wilmington, DE, USA). EGFP dsRNA was synthesized from the pEGFP-C1 plasmid (Takara Bio USA, Inc., Mountain View, CA, USA) for the control, and TcTRPM dsRNA was prepared in the same manner as previously reported29 (link). All dsRNA concentrations were adjusted to 2000 ng/μL using RNase-free water and injected into the pupal stage using a glass needle mounted with a micromanipulator (Narishige, Tokyo, Japan). After injection, the pupae were incubated in a 24-well plate set on a filter paper disk (ADVANTEC No.2) with a piece of whole-grain wheat with 5% of dried yeast at the bottom and incubated at 28 °C. After emergence, approximately 7-day-old adults were used for the area-preference test and subsequent qRT-PCR.
+ Open protocol
+ Expand
3

Overexpression of CK2α and Mismatch Repair Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pZW6(CK2α) vector for the overexpression of CK2α constructs containing an HA-tag was a gift from David Litchfield (Addgene plasmid # 27086; http://n2t.net/addgene:27086; RRID:Addgene_27086, accessed on 1 June 2020) [24 (link)]. The pZW6 mock control plasmid was generated by cutting out the CK2α-HA cDNA sequence and by relegation of the remaining vector. The pcDNA3.1+/MLH1 and pcDNA3.1+/PMS2 expression plasmids have been described earlier [25 (link)], the pcDNA3.1+/MLH1S477A variant has been previously described [9 (link)]. The pEGFP_C1 plasmid (negative control plasmid for transfection control) was purchased from Clontech Laboratories.
+ Open protocol
+ Expand
4

Characterization of MMR Protein Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-MLH1 (G168-728) and anti-PMS2 (A16-4) were purchased from Pharmingen (BD Biosciences, Heidelberg, Germany), anti-beta Actin (Clone AC-15) was from Sigma-Aldrich (Munich, Germany). Anti-phospho-AKT-substrate (23C8D2), hereinafter The pcDNA3.1+/MLH1 and pcDNA3.1+/PMS2 expression plasmids were described previously [12] . In addition, the MLH1-variants MLH1 S477A , MLH1 D478A and MLH1 E480A were generated by site-directed mutagenesis (for detailed primer information see supplementary table 1) and overexpressed in HEK293T cells.
All plasmids were confirmed by sequencing. All oligonucleotides were purchased from Sigma-Aldrich (Munich, Germany). pEGFP_C1 plasmid (negative control plasmid for the MMR assay) was purchased from Clontech Laboratories.
+ Open protocol
+ Expand
5

Cloning and Expression of U2AF35-EGFP in LLC-MK2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain the U2AF35-EGFP construct, we use LLC-MK2 cDNA as a template and U2AF35 specific primers (forward: 5’-GGATCCTCAGAATCGCCCAGATCTTT-3’ and reverse: 5’-CTCGAGTTGCGGAGTATCTGGCCTCCA-3’). Next, we cloned in a frame the U2AF35-EGFP sequence into a pEGFP-C1 plasmid (Clontech, USA) and confirmed the sequence by sequencing (ABI 3500 XL, Applied Biosystems, USA). LLC-MK2 cell line was transfected with 0,1 µg U2AF35-EGFP or 0,1 µg empty-EGFP vector using Lipofectamine 2000 (Thermo Fisher Scientific, USA), according to the manufacturer’s recommendations. Then, LLC-MK2 transfected cells were infected with T. cruzi and fixed with PBS/paraformaldehyde 2% for 10 min, then stained with DAPI and Rhodamine phalloidin as described above.
+ Open protocol
+ Expand
6

GST-TRAIL Apoptosis Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glutathione S-transferase (GST) TRAIL was prepared as described previously [Lin et al., 2000 (link)]. Antibodies against c-IAP-1 (AF8181), c-IAP2 (552782), FADD (556402), caspase-8 (551242), caspase-3 (559565) and p62 (610832) were from BD Biosciences (San Diego, CA, USA). Antibodies against GAPDH (sc-32233) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody against XIAP (2042) was from Cell Signaling (Danvers, MA, USA). Anti-poly (ADP-ribose) polymerase (PARP, ALX-210-222) and c-FLIP (ALX-804-961-0100) were from Enzo Life Sciences (Farmingdale, NY, USA). Antibody against LC3B (L7543) was purchased from Sigma-Aldrich (St Louis, MO, USA). Wortmannin (12-338) were Calbiochem (La Jolla, CA, USA). Chloroquine (C6628) and 3MA (M9281) were from Sigma-Aldrich. The pan-caspase inhibitor z-VAD-fmk (ALX-260-039) was from Enzo Life Sciences. Caspase-Glo® 3/7 Assay Systems (G8090) and Caspase-Glo® 8 Assay Systems (G8200) were from Promega (Madison, WI 53711 USA). The FLAG-cIAP1, FLAG-cIAP2 and pEBB-XIAP (which expresses FLAG-XIAP) plasmids were from Addgene (Cambridge MA) [Hu et al., 2006 (link); Hu and Yang, 2003 (link); Yang et al., 2000 (link)]. The pEGFP-C1 plasmid was from Clontech (Mountain View, CA). The V5-c-FLIP plasmid (HsCD00445121) was purchased from DNASU Plasmid Repository.
+ Open protocol
+ Expand
7

FAK and Paxillin Mutant Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
FAK-WT-GFP, FAK-Y397F-GFP and FAK-I936E I998E-GFP were obtained as previously described [17 (link)]. The LD2-LD4-GFP sequence of paxillin (aa 136–296) was inserted into the pEGFP–C1 plasmid (Clontech, Kusatsu City, Japan), creating a fusion of enhanced GFP (EGFP) to the N terminus of paxillin. Melanoma cells were co-transfected with siRNA and 4 µg FAK WT or FAK mutant DNA or with LD2-LD4-GFP DNA 4 µg using lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s instructions. Transfected cells were incubated for 24 h at 37 °C before use.
+ Open protocol
+ Expand
8

Construction of S. Typhimurium Toxin Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The S. Typhimurium strains MC1 and MC71 were previously described [35 (link)]. The genes encoding the typhoid toxin (TT) or a toxin carrying a deletion of the cdtB subunit (ΔcdtB) were cloned into the pEGFP-C1 plasmid (Clontech Laboratories, Mountain View, CA, USA) as described in [70 (link)]. The gene encoding the chloramphenicol resistance (Cm) was amplified from the pKD3 plasmid (NCBI Gene Bank AY048742), using the following primers: 5’-AAAGGATCCGTGTAGGCTGGAGCTGCTTC-3’ and 5’-AAAGGTACCCATATGAATATCCTCCTTAG-3’, and cloned into the BamHI-KpnI sites of the pEGFP-C1-TT or pEGFP-C1-ΔcdtB plasmids. The toxin and the chloramphenicol genes were amplified using the primers 5’-GTCCGCACGTTCTTCCGTGGCGTGGATATTAGTCAGGTCTTTAGCGCCAAAGATATTGCCATTCTGTAACTGATAAAGTAGGTGTGCTTA-3’ and 5’-AAT GCCGCTTTTAATGAGTCGATGGACACGACGCCCACGAATTTATTGCATATGAATATCCTCCTTAG-3’, and transferred by homologous recombination into the genomic proV gene of S. Typhimurium strain LB5010 [71 (link)] carrying the pKD46 plasmid [72 (link)]. The MC1/MC71-TT and MC1/MC71-ΔcdtB strains were produced by P22int phage transduction, and grown overnight in Luria agar plates supplemented with Cm (10 μg/ml) [73 (link)]. The construction of these strains was approved by the Swedish Work Environment Authority.
The list of strains used in this work is summarized in Table 1.
+ Open protocol
+ Expand
9

Transfection of Hippocampal Neurons and Neuro-2a Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hippocampal neurons were transfected at 7 DIV using Lipofectamine 2000 (Thermo Fisher, Cat# 11668019). Experiments were carried out after 20–24 hr. The pEGFP-C1 plasmid is from Clontech (Addgene plasmid # 13031, RRID:Addgene_13031), the plasmids for EGFP-Rab10 WT (RRID:Addgene_49472), EGFP-Rab10 T23N (RRID:Addgene_49545), and EGFP-Rab10 Q68L (RRID:Addgene_49544) were a gift from Marci Scidmore (Huang et al., 2010 (link)), TrkB-FLAG plasmid was a gift from Francis Lee (Chen et al., 2005 (link)). Neuro-2a cells were transfected using Lipofectamine 3000 (Thermo Fisher, Cat# L3000001) and the experiments were done 48 hr later. The GFP-KIF13B plasmid (RRID:Addgene_134626) was a gift from Marvin Bentley (Yang et al., 2019 (link)), whilst the HA-Rab10 plasmid was provided by Dario Alessi and Miratul Muqit (Dundee University, DU44250).
+ Open protocol
+ Expand
10

HDR-Mediated Restoration of Mutant eGFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate HDR efficiency, we employed a model system based on a single nucleotide frameshift deletion (c.337delG) in the eGFP gene. Mutated eGFP was stably integrated into the genome of HEK293T cells to create HEK293T-eGFPmut cells. The production of mutated eGFP involved site-directed mutagenesis of the peGFP-C1 plasmid (ClonTech, Mountain View, CA, USA), resulting in peGFP-C1mut. To integrate mutated eGFP into the cells, we used lentiviral particles generated from the pCMV-dR8.91 and pMD2.G plasmids, generously provided by Prof. Didier Trono (http://tronolab.epfl.ch, accessed on 31 March 2023). We constructed the pLVT_turboRFP635-eGFPmut plasmid by cloning the eGFPmut coding sequence and the turboRFP-635 far-red protein gene coding sequence, separated by a T2A linker, into the plot vector (Addgene, Watertown, MA, USA). Lentivirus particles assembled from pCMV-dR8.91, pMD2.G, and pLVT_turboRFP635-eGFPmut were used to infect HEK293T cells at a multiplicity of infection of 5–7. Successfully transfected cells were identified by far-red fluorescence from turbo-RFP635 encoded in the same pLVT_turboRFP635-eGFPmut vector. Functional GFP, generated by HDR-mediated restoration of the eGFP gene, produced green fluorescence in the edited cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!